TITLE

Candida dubliniensis: A rare cause of nail infection

AUTHOR(S)
J. Kalsy; J. Kaur
PUB. DATE
October 2012
SOURCE
Journal of Pakistan Association of Dermatologists;Oct-Dec2012, Vol. 22 Issue 4, p370
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Candida dubliniensis is a newly described fungal opportunistic pathogen that is closely related phylogenetically to C. albicans. It is mostly isolated from patients with immunodeficiency and few cases develop quick resistance to routine treatment and delay in result outcome. Here we report a case of 21-year-old healthy female who presented clinically with onychomycosis of the toe nail resistant to terbinafine and fluconazole.
ACCESSION #
90580736

 

Related Articles

  • Fungal nail dystrophy. Chittari, Kim; Ilchyshyn, Andrew // Update;Jul2007, Vol. 75 Issue 1, p21 

    The article presents information on the diagnosis and the topical and systemic antifungal therapy of nail infection. In onychomycosis, the concentration of fungus is highest in the nail bed. Sublingual debris should be collected from the most proximal and lateral portion of the affected nail bed...

  • Topical Solution for Nail Fungus. Preboth, Monica // American Family Physician;10/1/2001, Vol. 64 Issue 7, p1280 

    Reports on the approval of ciclopirox topical solution, 8 percent, for the treatment of onychomycosis by the United States Food and Drug Administration. Description of the solution and its use; Side effects.

  • AGAR BASED DRUG DIFFUSION ASSAY FOR IN VITRO SUSCEPTIBILITY TESTING OF DERMATOPHYTES. Sabokbar, Azar; Mirabdollahelahi, Seyedeh Shaghayegh; Riazipour, Majid; Alipour, Masoumeh // Jundishapur Journal of Microbiology;2013 Special Edition, p2 

    Introduction and Objectives: A standardized reference method for dermatophyte in vitro susceptibility testing is lacking. In the last two decades a plethora of studies have been done to establish an optimal antifungal susceptibility testing of dermatophytes. However, the earlier studies suffered...

  • Terbinafine Is More Effective Than Itraconazole In Treating Toenail Onychomycosis: Results from a Meta-analysis of Randomized Controlled Trials. Krob, Alexander H.; Fleischer Jr., Alan B.; D'Agostino, Ralph; Feldman, Steven R. // Journal of Cutaneous Medicine & Surgery;Jul/Aug2003, Vol. 7 Issue 4, p306 

    Background: Toenail onychomycosis is a challenge for clinicians to treat, and this challenge is compounded by conflicting information in the medical literature concerning the efficacy of the two principal agents used in its treatment: terbinafine and itraconazole. Objective: The purpose of this...

  • Treating Onychomycosis. Rodgers, Phillip; Bassler, Mary // American Family Physician;2/15/2001, Vol. 63 Issue 4, p663 

    Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents...

  • Newer antifungals valuable for onychomycosis. Guttman, Cheryl // Dermatology Times;Apr2002 Supplement 2, Vol. 23 Issue 4, pS14 

    Focuses on the antifungal agents for the treatment of onychomycosis on patients. Definition of onychomycosis; Efficacy of terbinafine and itraconazole in eradicating fungal nail infection; Restrictions on the administration of itraconazole in patients with evidence of ventricular dysfunction...

  • Toenail Cure Rates. Hill, Suzette // Dermatology Times;Jun2003, Vol. 24 Issue 6, p20 

    Discusses the efficacy of itraconazole and terbinafine in the treatment of toenail onychomycosis. Prognostic factors of mycological cure following treatment with oral antifungals; Use of mycological cultures at 24 weeks in improving treatment efficacy.

  • The Treatment Of Onychomycosis By Oral Terbinafine: The Efficacy And Adverse Events. Hassan, H. M.; Osman, A. M.; El-Moselhy, E. A. // Egyptian Journal of Hospital Medicine;Mar2008, Vol. 30, p70 

    Onychomycosis contributes to approximately half of all nail disorders and appears to be increasing in frequency. The main aim of this study was to access efficacy and adverse events of oral terbinafine in the treatment of adult patients with onychomycosis of the fingernails and toenails. Forty...

  • Common Fungal Infections of the Feet in Patients with Diabetes Mellitus. Tan, James S.; Joseph, Warren S. // Drugs & Aging;2004, Vol. 21 Issue 2, p101 

    Superficial fungal infections of the foot (tinea pedis and onychomycosis) are common among elderly patients. Although most authorities believe that patients with diabetes mellitus have an increased predisposition to dermatophytic infections, some controversies still remain. Because these...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics